HPSE and type 1 diabetes mellitus: In addition, heparanase inhibitors that have previously been shown to protect against islet inflammation, beta cell demise, and T1D development [16,25,30] may also be useful therapeutics for reducing pancreatic exocrine tissue inflammation.